¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary isotope effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® isotope ÇÑ±Û µ¿À§¿ø¼Ò
¼³¸í   
  ¿øÀÚ¹øÈ£´Â °°Áö¸¸ Áú·® ¼ö°¡ ´Ù¸¥ ¿ø¼Ò. µ¿À§Ã¼¶ó°íµµ ÇÑ´Ù. Isotope¶ó´Â ¸íĪÀº F. ¼Òµð°¡ ¸í¸íÇÑ °ÍÀÌ´Ù. µ¿À§¿ø¼Ò´Â º¸Åë¿ø¼Ò±âÈ£ÀÇ ¿ÞÂÊ ¾î±ú¿¡ Áú·®¼ö¸¦ ºÙ¿© Ç¥½ÃÇÑ´Ù. ÀϹÝÀûÀ¸·Î µ¿À§¿ø¼Ò´Â ¼ºÁúÀÌ ºñ½ÁÇÏÁö¸¸ ¿øÀÚ¹øÈ£°¡ ÀÛÀº ¿ø¼Ò, ¿¹¸¦ µé¾î ¼ö¼ÒÀÇ µ¿À§¿ø¼Ò(¼ö¼Ò 1H, Áß¼ö¼Ò 2H, 3Áß¼ö¼Ò 3H) µî¿¡¼­´Â È­ÇÐÀû ¼ºÁú±îÁöµµ ¾à°£ ´Ù¸¥µ¥°¡ ÀÖ´Ù. µ¿À§¿ø¼Ò¿¡´Â ¾ÈÁ¤ÇÑ µ¿À§¿ø¼Ò¿Í ºÒ¾ÈÁ¤ÇÑ ¹æ»ç¼ºµ¿À§¿ø¼Ò°¡ ÀÖ´Ù.
¿µ¹® adverse effect ÇÑ±Û ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
¼³¸í   
  ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇϴ °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇϴ Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, Æ¯È÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀΠ¿ªÈ¿°ú·Î¼­ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò
  • radioactive isotope
    ¹æ»ç¼ºµ¿À§¿ø¼Ò
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary
    ÀÏÂ÷-, ¿ø¹ß-
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • primary affect hunger
    ÀÏÂ÷Á¤µ¿°¥¸Á, ÀÏÂ÷¾ÖÁ¤°¥¸Á
  • primary aldosteronism
    ¿ø¹ß¾Ëµµ½ºÅ×·ÐÁõ
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ
  • primary amnion
    ÀÏÂ÷¾ç¸·, ¿ø½Ã¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ÀÏÂ÷¹æ¼ö, ¿ø¹æ¼ö
  • primary atelectasis
    ¿ø¹ß¹«±âÆó
  • primary atypical pneumonia
    ¿ø¹ßºñÁ¤ÇüÆó·Å
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò
  • effect
    È¿°ú, ÀÛ¿ë
  • adverse effect
    (¢¡ adverse event) À¯ÇذæÇè
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • reversing effect
    ¿ªÀüÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú, °¡¸²È¿°ú
  • stochastic effect
    È®·ü·ÐÀûÈ¿°ú
  • synergistic effect
    »ó½ÂÈ¿°ú
  • primary aldosteronism
    ÀÏÂ÷¾Ëµµ½ºÅ×·ÐÁõ
  • primary cancer
    ¿ø¹ß¾Ï
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò
  • radioactive isotope
    ¹æ»ç¼ºµ¿À§¿ø¼Ò
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ, ÀÏÂ÷¹«¿ù°æ
  • primary amnion
    ¿ø½Ã¾ç¸·, ÀÏÂ÷¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary olfactory receiving area
    ÀÏÂ÷Èİ¢¿µ¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • primary cancer
    ¿ø¹ß¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
  • primary cardiomyopathy
    ¿ø¹ß½ÉÀå±ÙÀ°º´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
  • Bohr effect
    º¸¾Æ È¿°ú(üùÍý)
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • Cytopath(ogen)ic effect, CPE
    ¼¼Æ÷º´º¯È¿°ú
  • Donnan effect
    µ·³­È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú
  • Fahraeus-Lindqvist effect
    ÆÄ·¹¿ì½º-¸°Äûºñ½ºÆ® È¿°ú(üùÍý)
  • Fenn effect
    Ææ È¿°ú(üùÍý)
  • Gibbs effect
    ±é½º È¿°ú
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò
  • isotope
    µ¿À§¿ø¼Ò(ÔÒêÈêªáÈ), ¾ÆÀ̼ÒÅäÇÁ.
  • isotope diagnosis
    µ¿À§¿ø¼ÒÁø´Ü.
  • isotope therapy
    µ¿À§¿ø¼ÒÄ¡·á
  • isotope therapy
    µ¿À§¿ø¼ÒÄ¡·á.
  • radioactive isotope therapy unit
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄ¡·á±â
  • stable isotope
    ¾ÈÁ¤µ¿À§¿ø¼Ò
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac[primary vitelline sac]
  • primary yolk sac[primary vitelline sac]
  • additive effect
    »ó°¡È¿°ú (ßÓÊ¥üùÍý)
  • additive effect
    ºÎ°¡È¿°ú
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Primary yolk sac [Primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Primary yolk sac [Primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Diploid primary gametocyte
    µÎ¹è¼öüÀÏÂ÷»ý½Ä¼¼Æ÷
    [¿¾ ¿ë¾î] ¹è¼öüÁ¦ÀÏ»ý½Ä¼¼Æ÷
  • Reticulofibrous membranous bone [Primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À [ÀÏÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÏÂ÷¸·¼º°ñ
  • Premaxilla (Primary palate)
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ¾ÇÀü±¸°³
  • Premaxilla [Primary palate]
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] Àü»ó¾Ç°ñ
  • Primary vitelline sac
    ¿ø½Ã³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ¿ø½Ã³­È²³¶
  • Primary amnion
    ¿ø½Ã¾ç¸·
    [¿¾ ¿ë¾î] ¿ø½Ã¾ç¸·
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£[ÀÏÂ÷»À¼ÓÁú°ø°£]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • Primary bronchus
    ÀÏÂ÷±â°üÁö
    [¿¾ ¿ë¾î] ¿ø½Ã±â°üÁö
  • Primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­¸ð¼¼Æ÷
  • Primary follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary amebic meningoencephalitis
    ¿ø¹ß¼º¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary infection
    ÀÏÂ÷°¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope effect
    µ¿À§¿ø¼Ò È¿°ú(ÔÒêÈêªáÈüùÍý)
  • kinetic isotope effect
    ¹ÝÀÀ¼Óµµ(ÚãëëáÜÓø) µ¿À§¿ø¼ÒÈ¿°ú(ÔÒêÈêªáÈüùÍý)
  • secondary isotope effect
    ÀÌÂ÷ µ¿À§¿ø¼ÒÈ¿°ú(ì£ó­ÔÒêÈêªáÈüùÍý)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • double isotope dilution analysis
    ÀÌÁß µ¿À§¿ø¼Ò Èñ¼®ºÐ¼®(ì£ñìÔÒêÈêªáÈýüà·ÝÂà°)
  • heavy isotope
    Áßµ¿À§¿ø¼Ò(ñìÔÒêÈêªáÈ)
  • isotope
    µ¿À§¿ø¼Ò(ÔÒêÈêªáÈ)
  • isotope derivative method
    µ¿À§¿ø¼ÒÀ¯µµÃ¼¹ý(ÔÒêÈêªáÈë¯Óôô÷Ûö)
  • isotope dilution analysis
    µ¿À§¿ø¼Ò Èñ¼®ºÐ¼®(ÔÒêÈêªáÈýüà·ÝÂà°)
  • isotope exchange
    µ¿À§¿ø¼Ò ±³È¯(ÔÒêÈêªáÈÎßüµ)
  • isotope incorporation
    µ¿À§¿ø¼Ò ÆíÀÔ(ÔÒêÈêªáÈøºìý)
  • light isotope
    °æµ¿À§¿ø¼Ò(ÌîÔÒêÈêªáÈ)
  • radioactive isotope
    ¹æ»ç¼º µ¿À§¿ø¼Ò(Û¯ÞÒàõÔÒêÈêªáÈ)
  • stable isotope
    ¾ÈÁ¤ µ¿À§¿ø¼Ò(äÌîïÔÒêÈêªáÈ)
  • primary acidosis
    ¿ø¹ß¼º »êÁõ(ê«Û¡àõß«ñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò, À̼ÒÅäÇÁ
  • isotope therapy
    µ¿À§¿ø¼ÒÄ¡·á
  • radioactive isotope
    ¹æ»ç¼ºµ¿À§¿ø¼Ò
  • stable isotope
    ¾ÈÁ¤¼ºµ¿À§¿ø¼Ò
  • primary
    ÀÏÂ÷(¼º)ÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ß(¼º)ÀÇ
  • primary amenorrhea
    ¿ø¹ß(¼º)¹«¿ù°æ
  • primary cancer
    ¿ø¹ß¾Ï
  • primary complex
    Ãʱ⺯ȭ±º
  • primary hypertension
    ¿ø¹ß(¼º)°íÇ÷¾ÐÁõ
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary infiltration
    ÃʱâħÀ±
  • primary lesion
    ÀÏÂ÷¼ºº´º¯, Ãʰ¨¿°¼Ò
  • primary lobule
    ÀÏÂ÷¼Ò¿±
  • primary ossification center
    ÀÏÂ÷°ñÈ­Áß½É
  • primary ray
    ÀÏÂ÷¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
BIC blood isotope clearance
DIC dicarbazine; differential interference contrast microscopy; diffuse intravascular coagulation; direc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GC-C-IRMS Gas chromatography-combustion-isotope ratio mass spectrometry
IDMS Isotope dilution mass spectrometry
IRMS Isotope ratio mass spectrometry
KIE Kinetic isotope effects
RI Radio Isotope
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • isotope diagnosis
    µ¿À§ ¿ø¼Ò Áø´Ü
  • radioactive isotope
    ¹æ»ç¼± µ¿À§¿ø¼Ò
  • stable isotope
    ¾ÈÁ¤ µ¿À§¿ø¼Ò, ¾ÈÁ¤¼º µ¿À§¿ø¼Ò
    ÀÔÀÚ¼±°ú ÀüÀÚ¼±ÀÇ ¹æÃâ µîÀ¸·Î ´Ù¸¥ ¿ø¼Ò·Î ÀüȯÇÏ´Â ÀÏÀÌ ¾ø´Â µ¿À§¿ø¼Ò.
  • primary vaccination :

    primary's area

    Á¦1¿µ¿ª
    ¿îµ¿°ú °¨°¢ºÎ¸¦ Æ÷ÇÔÇÏ´Â ´ë³ú ÇÇÁú ¿µ¿ª.
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
  • C primary afferent nociceptor
    C ÀÏÂ÷ ±¸½É¼º Ä§ÇØ ¼ö¿ëü, C ÀÏÂ÷ ±¸½É¼º À¯ÇØ ¼ö¿ë±â
  • early primary closure
    Á¶±â 1Â÷ ºÀÇÕ
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • myelinated primary afferent
    ÀÏÂ÷ À¯¼öÃÊ ±¸½É ½Å°æ
  • nociceptive primary afferent
    Ä§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ, À¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive A delta C primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ, ºñÀ¯ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive myelinated primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary
    ÀÏÂ÷¼º, ¿ø¹ß¼º, ¿ø¹ß¼ºÀÇ, ÀÏÂ÷, ÀÏÂ÷ÀÇ, ÀÏÂ÷¼ºÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ßÀÇ, ÁÖµÈ
    ¹ß»ýµÇ´Â ½Ã±âÀÇ ¼ø¼­¿¡ À־ óÀ½ÀÎ.
  • primary adaptation
    ÀÏÂ÷ ¼øÀÀ, ÀÏÂ÷¼º ¼øÀÀ
  • primary adrenocortical insuffciency
    ¿ø¹ß¼º ºÎ½Å ÇÇÁú ±â´É ºÎÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
radioactive isotope <physics, radiobiology> An isotope of an element that has an unstable nucleus, it tries to stabilise itself by giving off ionising radiation.
(09 Oct 1997)
stable isotope A nonradioactive nuclide; an isotope that shows no tendency to undergo radioactive decomposition.
(05 Mar 2000)
daughter isotope An element produced by radioactive decay of another.
See: radionuclide generator, cow.
(05 Mar 2000)
isotope <radiobiology> One of several nuclides having the same number of protons in their nuclei and hence having the same atomic number, but differing in the number of neutrons and therefore, in the mass number. Almost identical chemical properties exist between isotopes of a particular element. The use of this term as a synonym for nuclide is to be discouraged.
(16 Dec 1997)
isotope clearance The rate at which an isotope is removed (usually by blood flow) from a tissue or organ such as the brain.
(05 Mar 2000)
isotope labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labelled substances unless the methods of labeling are substantively discussed. Tracers that may be labelled include chemical substances, cells, or microorganisms.
(12 Dec 1998)
abscopal effect A reaction produced following irradiation but occurring outside the zone of actual radiation absorption.
(05 Mar 2000)
additive effect <biochemistry, chemistry> An additive effect is the overall biological effect two chemicals acting together and which is the simple sum of the effects of the chemicals acting independently.
Compare: antagonism.
(15 Jan 1998)
adverse effect This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical.
(09 Oct 1997)
Anrep effect A small transient positive inotropic effect of abrupt increases of systolic aortic and left ventricular pressures related to recovery from transient subendocardial ischemia (e.g., cold pressor test).
(05 Mar 2000)
antagonistic effect This is the consequence of one chemical (or group of chemicals) counteracting the effects of another chemical, the opposing chemicals cancel out each other's effects.
(09 Oct 1997)
Arias-Stella effect Focal, unusual, decidual changes in endometrial epithelium, consisting of intraluminal budding, and nuclear enlargement and hyperchromatism with cytoplasmic swelling and vacuolation; may be associated with ectopic or uterine pregnancy.
Synonym: Arias-Stella effect, Arias-Stella reaction.
(05 Mar 2000)
Auger effect <physics> Transition of an electron in an atom from a discrete electronic level to an ionised continuous level with the same energy.
Synonym: autoionisation.
(13 Jan 1998)
autokinetic effect In psychology, the apparent drifting about of a small, fixed, spot of light which is being observed in a dark room.
(05 Mar 2000)
Bernoulli effect <physics> The decrease in fluid pressure that occurs in converting potential to kinetic energy when motion of the fluid is accelerated, in accordance with Bernoulli's law.
Applied in water aspirators, atomisers, and humidifiers in which a gas is accelerated across the end of a narrow, fluid-filled orifice.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isotope
    µ¿À§¿ø¼Ò
  • carrierfree isotope
    È¥ÇÕ¹°ÀÌ ¾ø´Â ¹æ»ç¼º ¿ø¼Ò
  • isotope
    µ¿À§¿ø¼Ò;µ¿À§Ã¼;ÇÙÁ¾
  • radioactive isotope
    =RADIOISOTOPE
  • effect
    °á°ú,¿µÇâ,È¿°ú,½Ç½Ã,ÃÊ·¡ÇÏ´Ù
  • side effect
    ºÎÀÛ¿ë
  • Compton effect
    ÄÞÇÁÅÏ È¿°ú(±¤ÀÚ¿Í ÀüÀÚÀÇ Åº¼º »ê¶õ)
  • Donald Duck effect
    µµ³Îµå ´ö È¿°ú(¿ìÁÖ ºñÇàÁßÀÇ À½¼ºÀÇ °íÀ½È­ Çö»ó)
  • Doppler effect
    µµÇ÷¯ È¿°ú 
  • Gunn effect
    ¿µ±¹ Å»ýÀÇ ¹°¸®ÇÐÀÚ J.B.Gunn ÀÇ À̸§¿¡¼­
  • Raman effect
    ¶ó¸¸ È¿°ú(ºûÀÌ Åõ¸íÇÑ ¸ÅÁúÀ» Åë°úÇÒ ¶§,»ê¶õÇÏ¿© ºûÀÇ ÀϺΠÆÄÀåÀÌ º¯È­ÇÏ´Â Çö»ó)
  • cause-and-effect
    Àΰú °ü°èÀÇ
  • echo effect
    ¸Þ¾Æ¸® È¿°ú(¾î¶² ÀÏÀÌ µÚ´Ê°Ô µÇÇ®ÀÌ µÇ°Å³ª,±× °á°ú°¡ ´Ê°Ô ³ªÅ¸³ª´Â µîÀÇ Çö»ó)
  • effect
    °á°ú;¿µÇâ;È¿°ú;À¯È¿;´À³¦;Àλó;ºû±òÀÇ ¹èÇÕ;ÃëÁö;´ëÀÇ;¿Ü°ü;°á°ú¸¦ °¡Á®¿À´Ù;´Ù;¸ñÀûÀ» ÀÌ·ç´Ù
  • electrooptic effect
    (Àü)Àü±â ±¤ÇÐ È¿°ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á